Post by
fdfd12 on Nov 30, 2015 7:16am
CIBC TODAY
CXRX $47US with sector performer.
I guess notwrong is their analyst.
Comment by
fdfd12 on Nov 30, 2015 8:29am
Are their numbers right? That is when they say, $47 US is derived from "As of November 29, we are initiating coverage of Concordia Healthcare with a Sector Performer rating and a 12- to 18-month price target of $47, which is based on a 10x multiple of 2016E EV/EBITDA." He is saying the 2016EV/EBITDA will be $4.70US??? Is that right?
Comment by
USNOOZEULOOZE on Nov 30, 2015 9:36am
This post has been removed in accordance with Community Policy
Comment by
sunshine7 on Nov 30, 2015 9:39am
2016 guidance is Adjusted EBITDA2 of $610 million to $640 million. You do the math. Current cap is just over $2B. 10x is $6B or 3x current SP in USD or CD. Something I am missing?
Comment by
cg16 on Nov 30, 2015 9:49am
I think CIBC is factoring EV in there somehow? otherwise the math is as sunshine points out.
Comment by
notwrong on Nov 30, 2015 10:17am
This post has been removed in accordance with Community Policy
Comment by
fdfd12 on Nov 30, 2015 10:53am
Notwrong, you have accusations but nothing to back it up. Please tell me where Sushine doesn't show any knowledge. Notwrong, let's be mature about this.
Comment by
notwrong on Nov 30, 2015 1:26pm
This post has been removed in accordance with Community Policy
Comment by
healthstock1234 on Nov 30, 2015 11:04am
They will re-evaluate their position, for sure. All the rules in Europe are known by AMCo, for Concordia is not hard to understand them because they operate there by AMCo. It is not a new market! If I understand well, they are waiting the Consolidated Financial Statements to raise the target or not. In this case, they are not able to offer us an information.
Comment by
sunshine7 on Nov 30, 2015 9:30am
I see CXRX and USD nowhere. I assume CRX and CD only. Please confirm.
Comment by
USNOOZEULOOZE on Nov 30, 2015 9:59am
This post has been removed in accordance with Community Policy